BIOCHEMICAL
Vol. 2, No. 1
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Jan. 1960
THE REVERSIBLE INHIBITION OF SUCCINOXIDASE BY NAPHTHOGUI~NES David
Hendlin
and Thomas M. Cook
Merck Sharp & Dohme Research Laboratories Division of Merck & Co., Inc., Rahway, New Jersey Received
December
Ball,
1959
14,
and Cooper
Anfinsen,
(1947)
+alkylnaphthoqui
nones,
which
their
effect
on respiration
inhibitory
They pinpointed between recent
discovery
for
1957)
were
communication
inhibitory
effect
succinoxidase
system
of
(Crane,
of beef
antimalarial heart
also
between
transport
to
inhibit
chain
(Potter
as a
Hatefi,
Lester,
possibility
which
transport
2 and 2 in
l952),
that
demonstrate
compounds.
cytochromes
and Reif,
(CoOlo),
naphthoquinones
electron
by Co010 and related
The
system.
Co010 site.
studies
(ETP) can be reversed known
the
the
describes the
010
investigate at
to a site
transport
coenzyme
exert
succinoxidase.
compounds
electron
inhibiting
2-hydroxy-
activity,
by inhibiting
transport
us to
that
antimalarial
of these
the
electron
prompted
The present the
action
of a benzoquinone,
naphthoquinones
that
of
possess
2 and c in
essential
and Widmer,
the
locus
cytochromes
cofactor
the
the
demonstrated
is
not
on
particles Antimycin
the
electron
so antagonized.
METHODS The preparation previously
(Crane,
of these Crane,
particles Widmer,
unextracted
of
ETP from
Glenn,
and Green,
was determined Lester,
bovine
and Hatefi
heart
1956).
manometrically (1959).
enzyme was used and no phospholipid 71
has been
described
Succinoxidase according In the
present
was added
activity to studies to the
A,
Vol. 2, No. 1
reaction
BIOCHEMICAL
vessel.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
The tests
were conducted
1 mg of enzyme protein
containing 4
-I
260-
in a Warburg
in a total
A.
volume
vessel
of
1.5 ml.
B
I
‘)VNINHI8ITED ,’ CONTROL 1
220-
Jan. 1960
UNlNHl8lTED CONTROL
l
l80E e
l40-
zs k
IOO-
-I
0 Figure
IO
20
I
0
30
I
.
I
IO
.
,
20
30
MINUTES 1.
Reversal
of
Naphthoquindne
Inhibition
A. Inhibition by 2-hydroxy-3-(3’,7’-dimethyl) octyl-1,4-naphthoquinone. . (1) 1 pg naphthoquinone tipped into vessel. (2) 300 pg of indicated reversing agents tipped into vessel. B. Inhibition by 2-hydroxy-3-cyclohexylpropyl-1,4-naphthoquinone . (3) 10 pg naphthoquinone tipped into ve8sel. (4) 300 Pg CoQlg tipped into vessel. RESULTS The addition to
of
the l?TP system
‘the analogs
tested,
most potent. narrow
strongly
J-substituted inhibited
Fifty
2-hydroxynaphthoquinonss”
succinoxidase
the 3-(3’,7’-dimethyloctyl)
The inhibition
range.
* We wish available
several
to thank Prof. to us.
derivative
was proportional
per cent
inhibition
L. Fieser 72
for
activity.
Ofwas the
to the dose over occurred
making
these
with
0.5 Pg
compounds
a
Vol. 2, No. 1
BIOCHEMICAL
(1.6x10-9
moles)
erable
degree
reaction
and 1.0 pg caused
of protection
was obtained
studies
was reproducible
min Kl,
Complete
was obtained
and several
with
CoQlo analogs
methyl-21
butenyl),
The oxygen
uptake
in antimycin
A considCo010 in the
be reversed
not
Similar
reversal
of the
side
arm.
were obtained
occurred.
subsequent
to the This
6-(3’-
homolog
of CoQlO).
system,
compounds.
stopped
A toxicity
Higher
levels
by tipping could
not
of the naphtho-
CoQlo supplementation.
with
another
analog,
When 10 kg of complete
inhibition
addition
6-heptyl,
some of these
Antimycin
3-cyclohexylpropyl-l,&-naphthoquinone. pound were added
vita-
naphthoquinone
be completely
by further
be obtained
of Co010 hydroquinone
with
analogs.
effect
a-tocopherol,
6-farnesyl,
could
be reversed
results
as with
obtained
by CoQlO or its
could
as well
could
and the monoethoxy
so restored the
the protective
and reversal
(6-phytyl,
results
A from
that
the diacetate
6-methyl,
1A shows the
quinone
protection
of CoQlo analogs
and squalene.
inhibition
dase
inhibition.
by including
demonstrated
and that
a variety
Figure
complete
vessel.
More detailed
with
Jan. 1960
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
inhibition
was completely
of 300 pg Co010 (Fig.
2-hydroxythis
of
com-
succinoxf-
reversed
by the
18).
DISCUSSION Crane,
Widmer,
CoQlO functions area which If
Lester,
between
cytochromes
is sensitive
either
of these
be expected
that
inhibitors their reverse
nones but
not
antimycin
that
they
inhibit
acts
toxicity
indeed
naphthoquinones
(1959)
demonstrated
2 and 2.
This
to the naphthoquinones
Co010 did
of
and Hatefi
the
and antimycin at the
be
inhibitory
A.
is the
same
and antingrcin
at the Co010 site,
could
that
reversed effect
it
would
by CoQlO.
of the naphthoqui-
This
may indicate
that:
(a)
A act
at different
loci,
or (b)
same locus’but 73
that
A.
antimycin
the
A is more
Vol. 2, No. 1
BIOCHEMICAL
tenaciously
bound
The ability
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
to
the
enzyme.
of several
show no CoQLG activity), also sis
to reverse that
naphthoquinone
is apparent
be relieved
CoQLG analogs a-tocopherol,
naphthoquinones
It
act
quinones
findings
are reminiscent
of
and Wiss
(1958).
It
possible
is
1956;
(Mahler, around
the
blocked
of antimycin for
the
Weber,
of
obtained
If
such
for
ETP. “by-pass”
diacetates
their
electrons
then
the
A. of Co010
lipophilic
the naphthoquinone
site
to account
to antimycin
in
Gloor, the
transferring
must be different
may reside
They may act by displacing
by Weber,
is the case,
and the
squalene
can These
as an electron
1958)
and Wiss,
toxicity
isooctane-extracted
act
the “by-passe
Kl hydroquinones
on the hypothe-
requirement
of
the quinones
Gloor,
of
Kl
substances.
a similar
A and naphthoquinone
The activity vitamin
the results
reaction.
sensitivity
doubt
the naphthoquinone
E reductase
that
and vitamin
casts
or lipophilic
They observed
of cytochrome
squalene
which
those
at the CoQlD locus.
our data
from
(including
toxicity
by either
restoration
Jan. 1960
from
and
properties. the
lipoprotein
complex. It
is
evident
of naphthoquinones ies
should
sequence
that
the
will
require
be directed between
elucidation
at the
of
further
the
exact
site
Such stu-
investigation.
individual
of action
steps
in the
O.,
J. Biol.
Chem.,
D. E.,
Biochim.
et Bio-
reaction
k and 2.
cytochromes
REFERENCES Ball,
Anfinsen, 257 (1947).
E. G.,
9, Crane,
F. L.,
phys. Crane,
Glenn,
Acta,
22,
C. B.,
and Cooper,
J. L., and Green, 475 (1956).
F. L., Hatefi, Y., et Biophys. Acta, a,
Lester, R. L., 220 (1957). 74
and Widmer,
C.,
Biochim.
Vol. 2, No. 1
Crane,
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
F. L., Widrner, C., Lester, R. L., et Biophys. Acta, 2, 476 (1959).
Mahler,
H. R.,
Potter,
V. R. and Reif,
Weberll;SBIyloor,
Advances
U.,
in Eneymol, A. E.,
&
J. Biol.
and Wiss,
75
O.,
Helv.
and Hatefl,
Jan. 1960
Y.,
Biochim.
223 (1956). Chem., Chim.
l&, Acta,
287 (1952). &l,
1046